Clinical Trials Logo

Intracranial Hemmorhage clinical trials

View clinical trials related to Intracranial Hemmorhage.

Filter by:
  • None
  • Page 1

NCT ID: NCT01810276 Terminated - Clinical trials for Anti-platelet Therapy

Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury

PUNCH
Start date: June 2012
Phase: N/A
Study type: Interventional

The objective of this study is to determine if the administration of platelets will improve outcome in patients with ICH who are being treated with either aspirin, a thienopyridine (ticlodipine, clopidogrel, prasugrel) or a combination of both. The study has four specific aims: 1. To determine what affect platelet administration will have on bleeding in the brain. 2. To determine what affect platelet administration will have on brain function. Several assessments to test the functioning of the brain will be performed at enrollment and throughout the study. Comparing the results of these assessments between the experimental and control groups should allow us to determine if platelet administration improves outcomes in patients with bleeding in the brain exposed to antiplatelet therapy. 3. An important risk of reversing antiplatelet therapy is exposing the patient to the very complications this therapy was designed to prevent. Therefore, tracking complications will be a very important part of this study. The investigators will compare the rates of death, heart attack, stroke and clots in the veins between groups. 4. Some patients (10-40%) have limited responsiveness to antiplatelet therapy. While platelet responsiveness, as measured by a special platelet blood test, will not affect enrollment, the investigators feel it will be important to measure.